Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Axonics nets $128.3mm in IPO

Executive Summary

Axonics Modulation Technologies Inc. (neuromodulation device for urologic disorders) netted $128.3mm in its initial public offering of 9.2mm common shares (including the overallotment) at $15.00, the mid-point of its anticipated range. The company originally planned to offer 6.7mm shares.
Deal Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies